Answers are grounded in this paper and cite their sources.
n-type CuInS2 thin films were fabricated by a one-step electrodeposition of Cu/In/S precursors on a transparent fluorine-doped tin oxide (FTO) substrate followed by calcination in a mixture of N2 and H2 at 500 °C without the need of toxic H2S gas for sulfurization. The analyses of structural and optical properties revealed that tetragonal chalcopyrite CuInS2 thin films were obtained when heat treated in a mixture of 8% H2 and 92% N2; whereas calcination in pure N2 resulted in the formation of CuInS2 with a considerable amount of In2O3 and CuxS impurities. The synthesized n-CuInS2 thin film has an optical bandgap of 1.3 eV with the conduction band at ca. −1.2 V vs. Ag/AgCl at pH 6.5. The heat treatment in a mixture of H2 and N2 provided a reducing atmosphere to suppress the oxide formation of the electrodeposited Cu/In/S elements. It also increased the donor density of CuInS2 sixfold by increasing the density of the sulfur vacancies (known to be electron donors) at the grain surface. As a result of the improved purity and increased donor density, the hydrogen treated CuInS2 thin film yielded a photocurrent density of ∼8 mA cm−2 at 0.5 V vs. Ag/AgCl in 0.25 M Na2S and 0.35 M Na2SO3 under visible light illumination, which is a fourfold enhancement as compared to that obtained from the CuInS2 film calcined in pure N2.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: